Tanus T, Atkins P C, Zweiman B
Department of Medicine, University of Pennsylvania, Philadelphia, USA.
Clin Diagn Lab Immunol. 1996 Jan;3(1):135-7. doi: 10.1128/cdli.3.1.135-137.1996.
We found increased serum histamine-releasing activity (HRA) in 27% of patients with chronic idiopathic urticaria. Patterns of clinical manifestations were similar in those with and without serum HRA, including responses to a standard treatment regimen. In HRA+ patients the degree of serum HRA generally correlated with clinical disease activity.
我们发现,27%的慢性特发性荨麻疹患者血清组胺释放活性(HRA)升高。血清HRA阳性和阴性患者的临床表现模式相似,包括对标准治疗方案的反应。在HRA阳性患者中,血清HRA程度通常与临床疾病活动度相关。